Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease release » increased release (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
Showing 1 - 12 results of 12 for search '(( significant decrease release ) OR ( significant ((fold decrease) OR (point decrease)) ))~', query time: 0.48s Refine Results
  1. 1
    Release kinetics of GDNF from SIS with and without syndecan-3 (SDC3) added.

    Release kinetics of GDNF from SIS with and without syndecan-3 (SDC3) added. by Shiu-Jau Chen (21077803)

    Published 2025
    Save to List
    Saved in:
  2. 2
    DOX causes cell toxicity in AC16 cardiomyocyte cells.

    DOX causes cell toxicity in AC16 cardiomyocyte cells. by Lei Chen (54296)

    Published 2023
    Save to List
    Saved in:
  3. 3
    HSV-1 infection modulates the fatty acid synthase.

    HSV-1 infection modulates the fatty acid synthase. by Camilla Albano (16446679)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Depletion of SAMHD1 induces R-loop-mediated genome instability and cellular DNA damage response.

    Depletion of SAMHD1 induces R-loop-mediated genome instability and cellular DNA damage response. by Kiwon Park (6492266)

    Published 2021
    Save to List
    Saved in:
  5. 5
    LCAT is required for efficient asexual blood stage egress.

    LCAT is required for efficient asexual blood stage egress. by Abhinay Ramaprasad (521263)

    Published 2023
    Save to List
    Saved in:
  6. 6
    The transcriptional response of IECs to <i>C</i>. <i>albicans</i> infection is largely damage- and filamentation-independent.

    The transcriptional response of IECs to <i>C</i>. <i>albicans</i> infection is largely damage- and filamentation-independent. by Jakob L. Sprague (18087148)

    Published 2024
    “…The color scale represents the mean Log<sub>2</sub>(fold-change) of significant DEGs within each category. …”
    Save to List
    Saved in:
  7. 7
    Cilia disassembly proceeds at a faster rate in CCDC66-depleted cells, which is regulated by the AurkA-HDAC6 axis and rescued by microtubule stabilization.

    Cilia disassembly proceeds at a faster rate in CCDC66-depleted cells, which is regulated by the AurkA-HDAC6 axis and rescued by microtubule stabilization. by Jovana Deretic (13113617)

    Published 2025
    “…The mean cilia length in CCDC66-depleted cells decreased to 0.74-fold compared to the mean control length at 0 h. …”
    Save to List
    Saved in:
  8. 8
    DataSheet_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.docx

    DataSheet_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Findings<p>Elevated levels of anti-spike IgG antibodies were detected after CoronaVac vaccination, which significantly decreased after 80 days and remained stable until the introduction of the booster dose. …”
    Save to List
    Saved in:
  9. 9
    Table_3_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.docx

    Table_3_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Findings<p>Elevated levels of anti-spike IgG antibodies were detected after CoronaVac vaccination, which significantly decreased after 80 days and remained stable until the introduction of the booster dose. …”
    Save to List
    Saved in:
  10. 10
    Table_2_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.docx

    Table_2_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Findings<p>Elevated levels of anti-spike IgG antibodies were detected after CoronaVac vaccination, which significantly decreased after 80 days and remained stable until the introduction of the booster dose. …”
    Save to List
    Saved in:
  11. 11
    Table_4_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.docx

    Table_4_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Findings<p>Elevated levels of anti-spike IgG antibodies were detected after CoronaVac vaccination, which significantly decreased after 80 days and remained stable until the introduction of the booster dose. …”
    Save to List
    Saved in:
  12. 12
    Table_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.docx

    Table_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Findings<p>Elevated levels of anti-spike IgG antibodies were detected after CoronaVac vaccination, which significantly decreased after 80 days and remained stable until the introduction of the booster dose. …”
    Save to List
    Saved in:

Search Tools: